Do you want to read an article? Please log in or register.
SPECT/CT Accurately Predicts Postoperative Lung Function in Patients with Limited Pulmonary Reserve Undergoing Resection for Lung Cancer
Lung Cancer
Related content
RECOMMENDED
Lung Cancer
Long term outcomes after lobar versus sublobar resection for patients with Non-Small cell lung Cancer: Systematic review and individual patient data Meta-Analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Tasoudis P, Loufopoulos G, Manaki V, Doerr M, Agala CB, Long JM, Haithcock BE
doi: 10.1016/j.lungcan.2024.107929
RECOMMENDED
Lung Cancer
CT-assessed sarcopenia and immune-related adverse events in patients with lung cancer: A competing risk time-to-event analysis
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lung Cancer
Suazo-Zepeda E, Viddeleer AR, Maas WJ, Postmus D, Heuvelmans MA, Hiltermann TJN, De Bock GH
doi: 10.1016/j.lungcan.2024.108054
RECOMMENDED
COPDInterstitial Lung Disease
Pulmonary Rehabilitation and Functional Independence: Impact on Survival in Patients with Fibrotic Interstitial Lung Disease or Chronic Obstructive Pulmonary Disease
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 3
Recommended by
Dr Marcus Hesse, Faculty Member
Respir Med
Elmiger A, Marcin T, Bovet L, Brun P, Guler SA
doi: 10.1016/j.rmed.2024.107933
Lung Cancer
The impact of lung surgery, with or without (neo-)adjuvant therapy, on physical functioning in patients with nonsmall cell lung cancer: a scoping review
Eur Respir Rev
Haesevoets S, Arents E, Cops D, Quadflieg K, Criel M, Ruttens D, Daenen M, Stevens D, Surmont V, Demeyer H, Burtin C
doi: 10.1183/16000617.0156-2024
Pulmonary Fibrosis
Changes in Lung Function and Mortality Risk in Patients With Idiopathic Pulmonary Fibrosis
Chest
Oldham JM, Neely ML, Wojdyla DM, Gulati M, Li P, Patel DC, Palmer SM, Todd JL, Idiopathic Pulmonary Fibrosis-Prospective Outcomes Registry Investigators
doi: 10.1016/j.chest.2025.02.018
RECOMMENDED
Lung Cancer
Completion Rates for Patients Undergoing Concurrent Chemoradiotherapy for Stage III Nonsmall Cell Lung Cancer and its Importance in the Era of Consolidation Immunotherapy: A Cohort Study
★ 1
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Clin Lung Cancer
Wallace ND, Xie J, Alexander M, Ball D, Hegi-Johnson F, Plumridge N, Siva S, Shaw M, Harden S, John T, Solomon B, Irving L, Duffy M, Officer A, MacManus M
doi: 10.1016/j.cllc.2025.02.010
RECOMMENDED
Pulmonary Fibrosis
Lung Function Course of Patients With Pulmonary Fibrosis After Initiation of Anti-Fibrotic Treatment: Real-World Data From the Dutch National Registry
★ 2
Recommended by
Dr Martin Frey, Faculty Member
Respirology
Platenburg MGJP, Nakshbandi G, Moor CC, van Batenburg AA, Mostard RLM, Voortman M, Moonen L, Hekelaar N, Overbeek MJ, Bogaarts B, Kramer H, Marges E, Boerrigter BB, Bresser P, Schakenraad E, van der Maten J, van der Sloot CA, Walen S, Afonso PM, Wijsenbeek MS, Grutters JC
doi: 10.1111/resp.70030
Lung Cancer
Advanced Lung Cancer Inflammation Index as Predictor of All-Cause Mortality in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention
J Clin Med
Trimarchi G, Pizzino F, Lilli A, De Caterina AR, Esposito A, Dalmiani S, Mazzone A, Di Bella G, Berti S, Paradossi U
doi: 10.3390/jcm13206059
RECOMMENDED
Lung Cancer
Perioperative tislelizumab plus neoadjuvant chemotherapy for patients with resectable non-small-cell lung cancer (RATIONALE-315): an interim analysis of a randomised clinical trial
★ 2
Recommended by
Dr Martin Frey, Faculty Member
★ 1
Recommended by
Dr Marcus Hesse, Faculty Member
Lancet Respir Med
Yue D, Wang W, Liu H, Chen Q, Chen C, Liu L, Zhang P, Zhao G, Yang F, Han G, Cheng Y, Yu B, Yang Y, Chen H, Jiang J, Tan L, Xu S, Mao N, Hu J, Zhang L, Yao B, Wang S, Wang RH, Zheng W, Wang C, RATIONALE-315 investigators
doi: 10.1016/S2213-2600(24)00269-8